Raharjo Sentot Joko, Kikuchi Takeshi
Academic of Pharmacy and Food Analysis. Graduate Life Science School, Ritsumeikan University, Biwako Kutsasu Campus, Shiga Prefecture, Japan.
Acta Inform Med. 2016 Oct;24(5):332-337. doi: 10.5455/aim.2016.24.332-337. Epub 2016 Nov 1.
Virtual molecular dynamic sesquiterpenoid Pogostemon Herba (CID56928117, CID94275, CID107152, and CID519743) have screening as cyclooxygenase (COX-1/COX-2) selective inhibitor.
Molecular interaction studies sesquiterpenoid compounds with COX-1 and COX-2 were using the molecular docking tools by Hex 8.0 and interactions were further visualized using by Discovery Studio Client 3.5 software tool and Virtual Molecular Dynamic 1.9.1 software. The binding energy calculation of molecular dynamic interaction was calculated by AMBER12 software.
The analysis of the sesquiterpenoid compounds showed that CID56928117, CID94275, CID107152, and CID519743 have suggested as inhibitor of COX-1 and COX-2.
Collectively, the scoring binding energy calculation (with PBSA Model Solvent) sesquiterpenoid compounds: CID519743 had suggested as candidate for non-selective inhibitor; CID56928117 and CID94275 had suggested as candidate for a selective COX-1 inhibitor; and CID107152 had suggested as candidate for a selective COX-2 inhibitor.
对虚拟分子动力学倍半萜类广藿香(CID56928117、CID94275、CID107152和CID519743)进行筛选,以确定其作为环氧化酶(COX - 1/COX - 2)选择性抑制剂的可能性。
使用Hex 8.0分子对接工具对倍半萜类化合物与COX - 1和COX - 2进行分子相互作用研究,并通过Discovery Studio Client 3.5软件工具和虚拟分子动力学1.9.1软件进一步可视化相互作用。分子动力学相互作用的结合能计算由AMBER12软件完成。
倍半萜类化合物分析表明,CID56928117、CID94275、CID107152和CID519743被认为是COX - 1和COX - 2的抑制剂。
总体而言,通过(使用PBSA模型溶剂)对倍半萜类化合物进行评分结合能计算得出:CID519743被认为是非选择性抑制剂的候选物;CID56928117和CID94275被认为是选择性COX - 1抑制剂的候选物;CID107152被认为是选择性COX - 2抑制剂的候选物。